Vima LLC Cybin Inc. Transaction History

Vima LLC

$348 Million
Q1 2024

A detailed history of Vima LLC transactions in Cybin Inc. stock. As of the latest transaction made, Vima LLC holds 795 shares of CYBN stock, worth $206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

795

Previous 250 218.0%

Holding current value

$206

Previous $612,000 100.0%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 17, 2024	BUY	$0.3 - $0.46 $163 - $250	545 Added 218.0%	795 $0
Q4 2023 Mar 04, 2024	BUY	$0.38 - $0.65 $94 - $161	248 Added 12400.0%	250 $612,000
Q4 2023 Feb 16, 2024	BUY	$0.38 - $0.65 $0 - $1	2 New	2 $226,000

Others Institutions Holding CYBN

# of Institutions

108

Shares Held

243M

Call Options Held

Put Options Held

Deep Track Capital, LP Greenwich, CT

58.1M
Shares

$15.1 Million
0.79% of portfolio
Logos Global Management LP San Francisco, CA

40M
Shares

$10.4 Million
1.53% of portfolio
Avidity Partners Management LP Dallas, TX

34.9M
Shares

$9.07 Million
0.55% of portfolio
Sphera Funds Management Ltd. Tel Aviv, L3

25.6M
Shares

$6.65 Million
1.64% of portfolio
Octagon Capital Advisors LP New York, NY

18.6M
Shares

$4.84 Million
1.19% of portfolio

View Full List

About CYBIN INC.

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

More about CYBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vima LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vima LLC with notifications on news.

Account